Universe Pharmaceutical Class AUPC
13F holders, Q2 2026 (June 30)4holders +3
4new positions
0sold out
$6.10avg. 13F price*
At the end of Q2 2026, 4 institutions reported holding Universe Pharmaceutical Class A (UPC) in their 13F filings, up 3 from Q4 2025. 4 opened new positions and 0 sold out. The largest holders were HRT Financial LP ($103K), UBS Group AG ($88K) and Osaic Holdings, Inc. ($38K).
- Company
- Universe Pharmaceutical Class A
- CUSIP
- G9442G138
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $228K |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q2 2026: 37,453 shares bought, net +37,453 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| HRT Financial LP | 0.00% | New | 16,902 | $103K |
| UBS Group AG | 0.00% | New | 14,367 | $88K |
| Osaic Holdings, Inc. | 0.00% | New | 6,172 | $38K |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 12 | $73 |
"% of holder's portfolio" is UPC's weight in each manager's 13F, not the share of Universe Pharmaceutical Class A the manager owns.